Haemonetics Corp
HAE50.600USD
-0.550-1.08%
Fechamento 09/19, 16:00（ET）Cotações atrasadas em 15 min
2.44BValor de mercado
14.92P/L TTM
Mais detalhes de Haemonetics Corp Empresa
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Informações da empresa
Código da empresaHAE
Nome da EmpresaHaemonetics Corp
Data de listagemOct 17, 1979
CEOMr. Christopher A. Simon
Número de funcionários3023
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 17
Endereço125 Summer Street
CidadeBOSTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal02110
Telefone17818487100
Sitehttps://www.haemonetics.com
Código da empresaHAE
Data de listagemOct 17, 1979
CEOMr. Christopher A. Simon
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.24K
+12.76%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
+21.20%
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
+60.75%
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.39K
--
Mr. Frank W. Chan
Mr. Frank W. Chan
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.24K
+12.76%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
1.01B
74.29%
Europe
175.66M
12.91%
Asia
92.31M
6.78%
Japan
62.41M
4.59%
other
19.54M
1.44%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qua, 27 de ago
Atualizado em: qua, 27 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.56%
The Vanguard Group, Inc.
10.26%
Neuberger Berman, LLC
8.88%
Wellington Management Company, LLP
4.46%
State Street Global Advisors (US)
3.91%
Outro
60.94%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.56%
The Vanguard Group, Inc.
10.26%
Neuberger Berman, LLC
8.88%
Wellington Management Company, LLP
4.46%
State Street Global Advisors (US)
3.91%
Outro
60.94%
Tipos de investidores
Investidores
Proporção
Investment Advisor
52.55%
Investment Advisor/Hedge Fund
49.82%
Hedge Fund
5.32%
Research Firm
4.12%
Bank and Trust
1.39%
Pension Fund
1.35%
Individual Investor
1.19%
Sovereign Wealth Fund
1.11%
Insurance Company
0.04%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
700
57.31M
118.95%
-4.19M
2025Q1
723
57.94M
120.44%
-3.07M
2024Q4
701
58.48M
116.40%
-1.44M
2024Q3
689
57.60M
112.60%
-1.51M
2024Q2
668
57.60M
113.31%
+3.07M
2024Q1
655
52.49M
103.35%
-1.26M
2023Q4
647
51.85M
102.19%
-3.31M
2023Q3
657
52.00M
102.54%
-4.11M
2023Q2
656
51.75M
102.38%
-4.68M
2023Q1
715
51.58M
102.24%
-8.44M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
5.67M
11.79%
+31.09K
+0.55%
Mar 31, 2025
The Vanguard Group, Inc.
5.09M
10.59%
-80.50K
-1.56%
Mar 31, 2025
Neuberger Berman, LLC
4.35M
9.05%
-70.98K
-1.61%
Mar 31, 2025
Wellington Management Company, LLP
2.62M
5.46%
-1.32M
-33.38%
Mar 31, 2025
State Street Global Advisors (US)
1.92M
3.99%
-28.97K
-1.49%
Mar 31, 2025
River Road Asset Management, LLC
1.40M
2.9%
+1.04M
+295.76%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
2.20M
4.57%
-358.25K
-14.03%
Mar 31, 2025
Royce Investment Partners
1.16M
2.42%
+8.03K
+0.70%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.22M
2.54%
+40.32K
+3.41%
Mar 31, 2025
Capital Research Global Investors
1.58M
3.28%
-2.66M
-62.79%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de set
Atualizado em: sáb, 6 de set
Nome
Proporção
Harbor Human Capital Factor US Small Cap ETF
1.78%
SPDR S&P Health Care Equipment ETF
1.45%
First Trust Small Cap Growth AlphaDEX Fund
0.28%
Fidelity Small-Mid Multifactor ETF
0.15%
Global X Russell 2000 ETF
0.15%
Vanguard S&P Mid-Cap 400 Growth Index Fund
0.14%
Invesco Dynamic Buyback Achievers ETF
0.12%
Nuveen ESG Small-Cap ETF
0.11%
Vanguard S&P Mid-Cap 400 Value Index Fund
0.11%
SPDR S&P 400 Mid Cap Growth ETF
0.1%
Ver Mais
Harbor Human Capital Factor US Small Cap ETF
Proporção1.78%
SPDR S&P Health Care Equipment ETF
Proporção1.45%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.28%
Fidelity Small-Mid Multifactor ETF
Proporção0.15%
Global X Russell 2000 ETF
Proporção0.15%
Vanguard S&P Mid-Cap 400 Growth Index Fund
Proporção0.14%
Invesco Dynamic Buyback Achievers ETF
Proporção0.12%
Nuveen ESG Small-Cap ETF
Proporção0.11%
Vanguard S&P Mid-Cap 400 Value Index Fund
Proporção0.11%
SPDR S&P 400 Mid Cap Growth ETF
Proporção0.1%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
